Iovance Biotherapeutics Inc. Common Stock vs SK Hynix — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B), while SK Hynix trades at $169.75 (market cap $891.31B). The key difference: SK Hynix is far larger — about 147.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and SK Hynix pays a 0.06% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and SK Hynix for 10 Days on average.
| IOVA | SKHY | |
|---|---|---|
Market Cap | $6.04B | $891.31B |
Volume | 14,805,993 | 22,268,296 |
Sector | Health | Technology |
52-Week High | $14.82 | $198.63 |
52-Week Low | $1.81 | $126.79 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $5.97B | $841.45B |
Dividend Yield | — | 0.06% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →